Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology Industry by Canadian Healthcare Marketing Hall of Fame

Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology Industry by Canadian Healthcare Marketing Hall of Fame

30-year Industry Veteran Advocate for Advancing Science, Innovation and Canadian Competitiveness

TORONTO, April 11, 2013 /CNW/ - Mark Lievonen, President of Sanofi Pasteur Limited, the Canadian vaccine division of the Sanofi Group, has been inducted into the 2013 Canadian Marketing Healthcare Hall of Fame Award, in recognition of his outstanding contributions to the healthcare industry.

The Canadian Healthcare Marketing Hall of Fame was established in 1988 to honour lifetime achievement in healthcare marketing. This award is the highlight of the annual National Pharmaceutical Congress organized by the Chronicle Companies.

"Through a career spanning over 30 years, Mark Lievonen has made a lasting impact on the industry and served as a source of inspiration to others," said Mitchell Shannon, Publisher, The Chronicle Newspapers, which sponsors the award. "The judging committee was impressed by Mr. Lievonen's extraordinary dedication and commitment to the profession. Under his leadership, Sanofi Pasteur has become a billion dollar enterprise in Canada, and is a symbol of Canadian talent, innovation and R&D excellence."

Lievonen is an active member in the life sciences sector. He is a member of several organizations, notably: Director, Oncolytics Biotech Inc.; Vice-Chair, Ontario Institute for Cancer Research; First Vice-Chair, Rx&D; Chair, Markham Stouffville Hospital Foundation; Director, Public Policy Forum; Governor, York University; Director, BIOTECanada; Director, Markham Stouffville Hospital; and Director, York University Development Corporation.

"I am truly honoured to receive this recognition on behalf of Sanofi Pasteur, my colleagues and my community, and I am proud that we have been able to play a small part in preventing disease and saving lives in Canada and all around the world," says Mark Lievonen.  "I am energized by the work we do, inspired by my passionate colleagues and humbled by our role in impacting human lives each and every day."

Lievonen has been the recipient of the Queen's Golden Jubilee Medallion (2002), the Chevalier de l'Ordre National de Mérite by the Government of France (2007), Fellow, Ontario Institute of Chartered Accountants (2009) and received the Queen's Diamond Jubilee Medallion (2012). Twenty years ago, Lievonen also spearheaded Canada's only mentored science competition, the Sanofi BioGENEius Challenge Canada (SBCC), to foster biotechnology talent in Canada among high school students.  For a complete biography click here.

Mark Lievonen joined Sanofi Pasteur Canada in 1983 and has been the President since 1999. For almost 100 years, Sanofi Pasteur has been at the forefront of innovation in vaccine R&D, and has made more than $600 million in capital expenditures since 2000.  The company manufactures over 50 million doses of vaccines in Canada for both domestic and international markets, and is the only manufacturer of 5-component acellular pertussis combination vaccines, which was launched in Canada as Pentacel® in 1997.  Sanofi Pasteur has a broad vaccine portfolio in Canada, including Pediacel®, Menactra®, Adacel®, Intanza®, Vaxigrip®, ViVaxim®, Typhim Vi® and YF-Vax®.

Nominations for the 2013 selection of honorees were solicited during the past months from the publication's readers.  Since 1988, 95 healthcare visionaries, original thinkers and leaders have been honoured with this prestigious distinction. Numerous submissions were received and a committee consisting of the publications' editors and an ad hoc group of industry advisors undertook the difficult task of determining from among the Nominees the candidates who best exemplified the qualities described above, based on the information submitted by the individual(s) making the nomination.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit:

Media Contacts: Nancy Simpson Sanofi Pasteur Tel: 416-667-2955

Kara LATTA CASACOM Tel: 416-944-2145

Image with caption: "Mark Lievonen, President, Sanofi Pasteur Limited is inducted into the Canadian Healthcare Marketing Hall of Fame Award by Mitchell Shannon, Publisher, The Chronicle Newspapers at the Canadian Pharmaceutical Congress, held yesterday at the Mississauga Convention Centre. (CNW Group/Sanofi Pasteur Inc.)". Image available at:

SOURCE: Sanofi Pasteur Inc.

To view this news release in HTML formatting, please use the following URL:

CO: Sanofi Pasteur Inc. ST: Ontario NI: BTC MTC ENT

-0- Apr/11/2013 17:13 GMT

Sponsored Links
Sponsored Links